{
    "Trade/Device Name(s)": [
        "ADVOCATE\u00ae Redi-Code* BMB-EA001S Blood Glucose Monitoring System",
        "ADVOCATE\u00ae Redi-Code* BMB-EA004S Blood Glucose meter",
        "ADVOCATE\u00ae Redi-Code* BMB-BA006A Blood Glucose test strips",
        "ADVOCATE\u00ae Redi-Code* control solutions"
    ],
    "Submitter Information": "BroadMaster Biotech Corporation",
    "510(k) Number": "K120183",
    "Predicate Device Reference 510(k) Number(s)": [
        "K102316"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "April 10, 2012",
    "Summary Letter Received Date": "April 11, 2012",
    "Submission Date": "January 20, 2012",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVOCATE\u00ae Redi-Code* BMB-EA004S Blood Glucose meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric method",
        "Glucose oxidase"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strips",
        "Control Solution",
        "Lancing Device"
    ],
    "Document Summary": "FDA 510(k) summary for ADVOCATE\u00ae Redi-Code* BMB-EA001S Blood Glucose Monitoring System for quantitative glucose measurement in capillary whole blood for at-home diabetes monitoring.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood at home from various sites, as an aid in monitoring effectiveness of diabetes control; not for diagnosis or neonatal testing, for single-person use only.",
    "fda_folder": "Clinical Chemistry"
}